Literature DB >> 12161536

Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction.

Michihiro Yoshimura1, Shota Nakamura, Teruhiko Ito, Masafumi Nakayama, Eisaku Harada, Yuji Mizuno, Tomohiro Sakamoto, Megumi Yamamuro, Yoshihiko Saito, Kazuwa Nakao, Hirofumi Yasue, Hisao Ogawa.   

Abstract

We have shown that aldosterone, previously thought to be synthesized solely in the adrenal cortex, is also produced in the failing human heart. One way to induce aldosterone synthesis in the heart would be to increase the expression of CYP11B2, the enzyme catalyzing the terminal step in aldosterone synthesis. However, CYP11B2 expression has never been examined in cardiac tissue from patients with heart failure. We assayed CYP11B2 expression in left ventricular tissue obtained at autopsy from seven patients. Total RNA was extracted from frozen samples. CYP11B2 gene expression was then quantitatively analyzed using a modified real-time PCR method that enabled assay of samples containing very small amounts of template DNA. The template DNA was initially amplified 1024-fold by subjecting it to 10 PCR cycles in the absence of the TaqMan probe. Thereafter, conventional real-time PCR was simultaneously performed on both target and standard samples. We measured the small quantities of CYP11B2 gene transcript and found the levels to be significantly higher in samples from heart failure patients than in those from cardiovascular disease-free patients. Our modified real-time PCR method enables quantitative analysis of gene expression using very small amounts of template DNA. CYP11B2 expression is up-regulated in the failing human heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161536     DOI: 10.1210/jcem.87.8.8731

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.

Authors:  S Kasama; T Toyama; T Hatori; H Sumino; H Kumakura; Y Takayama; S Ichikawa; T Suzuki; M Kurabayashi
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

2.  Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide.

Authors:  Shu Kasama; Takuji Toyama; Toshiya Iwasaki; Hiroyuki Sumino; Hisao Kumakura; Kazutomo Minami; Shuichi Ichikawa; Naoya Matsumoto; Tomoaki Nakata; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09       Impact factor: 9.236

Review 3.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

4.  Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy.

Authors:  Jessica A Chadwick; Sarah A Swager; Jeovanna Lowe; Steven S Welc; James G Tidball; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

5.  Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-01       Impact factor: 9.236

6.  Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice.

Authors:  Atsushi Hashimoto; Yoshimichi Takeda; Shigehiro Karashima; Mitsuhiro Kometani; Daisuke Aono; Masashi Demura; Takuya Higashitani; Seigo Konishi; Takashi Yoneda; Yoshiyu Takeda
Journal:  Hypertens Res       Date:  2020-05-12       Impact factor: 3.872

Review 7.  DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases.

Authors:  Yoshimichi Takeda; Masashi Demura; Takashi Yoneda; Yoshiyu Takeda
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

8.  Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.

Authors:  Eric E Essick; Flora Sam
Journal:  Int J Hypertens       Date:  2011-05-22       Impact factor: 2.420

Review 9.  Optimization of cardiac metabolism in heart failure.

Authors:  Tomohisa Nagoshi; Michihiro Yoshimura; Giuseppe M C Rosano; Gary D Lopaschuk; Seibu Mochizuki
Journal:  Curr Pharm Des       Date:  2011-12       Impact factor: 3.116

10.  Rapid induction of aldosterone synthesis in cultured neonatal rat cardiomyocytes under high glucose conditions.

Authors:  Masami Fujisaki; Tomohisa Nagoshi; Tetsuo Nishikawa; Taro Date; Michihiro Yoshimura
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.